Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.

Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hüll M, Frölich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J.

Neurology. 2012 Feb 7;78(6):379-86. doi: 10.1212/WNL.0b013e318245f447. Epub 2012 Jan 11.

PMID:
22238414
[PubMed - indexed for MEDLINE]
2.

Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients.

Rami L, Fortea J, Bosch B, Solé-Padullés C, Lladó A, Iranzo A, Sánchez-Valle R, Molinuevo JL.

J Alzheimers Dis. 2011;23(2):319-26. doi: 10.3233/JAD-2010-101422.

PMID:
21098971
[PubMed - indexed for MEDLINE]
3.

Longitudinal changes of CSF biomarkers in Alzheimer's disease.

Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK.

J Alzheimers Dis. 2011;25(4):583-94. doi: 10.3233/JAD-2011-101911.

PMID:
21460434
[PubMed - indexed for MEDLINE]
4.

Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease.

Haldenwanger A, Eling P, Kastrup A, Hildebrandt H.

J Alzheimers Dis. 2010;22(3):971-80. doi: 10.3233/JAD-2010-101203.

PMID:
20858947
[PubMed - indexed for MEDLINE]
5.

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.

Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O.

Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155.

PMID:
22213792
[PubMed - indexed for MEDLINE]
6.

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'Italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ.

Neurobiol Aging. 2012 Oct;33(10):2272-81. doi: 10.1016/j.neurobiolaging.2011.12.017. Epub 2012 Jan 20.

PMID:
22264648
[PubMed - indexed for MEDLINE]
7.

[Patients with mild cognitive impairment and a reduced CSF Aβ₁₋₄₂ protein progress rapidly to Alzheimer's disease].

Monge-Argilés JA, Sánchez-Payá J, Muñoz-Ruiz C, Pampliega-Pérez A, Gómez-López MJ, Rodríguez Borja E, Montoya-Gutiérrez J, Leiva-Santana C.

Neurologia. 2012 Jan;27(1):28-33. doi: 10.1016/j.nrl.2011.03.014. Epub 2011 May 31. Spanish.

PMID:
21621878
[PubMed - indexed for MEDLINE]
Free Article
8.

Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.

Ivanoiu A, Adam S, Van der Linden M, Salmon E, Juillerat AC, Mulligan R, Seron X.

J Neurol. 2005 Jan;252(1):47-55.

PMID:
15654553
[PubMed - indexed for MEDLINE]
9.

Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.

Parnetti L, Chiasserini D, Eusebi P, Giannandrea D, Bellomo G, De Carlo C, Padiglioni C, Mastrocola S, Lisetti V, Calabresi P.

J Alzheimers Dis. 2012;29(1):229-38. doi: 10.3233/JAD-2011-111349.

PMID:
22232006
[PubMed - indexed for MEDLINE]
10.

Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.

Nordlund A, Rolstad S, Klang O, Lind K, Pedersen M, Blennow K, Edman A, Hansen S, Wallin A.

J Int Neuropsychol Soc. 2008 Jul;14(4):582-90. doi: 10.1017/S135561770808079X.

PMID:
18577287
[PubMed - indexed for MEDLINE]
11.

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Frisoni GB, Froelich L, Nobili F, van der Flier W, Blennow K, Wolz R, Scheltens P, Visser PJ.

Neurology. 2013 Mar 19;80(12):1124-32. doi: 10.1212/WNL.0b013e318288690c. Epub 2013 Feb 27.

PMID:
23446677
[PubMed - indexed for MEDLINE]
12.

Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations.

Wallin A, Göthlin M, Gustavsson M, Zetterberg H, Eckerström C, Blennow K, Edman A, Lind K, Nordlund A, Rolstad S.

Dement Geriatr Cogn Disord. 2011;32(3):193-7. doi: 10.1159/000333034. Epub 2011 Nov 3.

PMID:
22057225
[PubMed - indexed for MEDLINE]
13.

Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.

Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.

PMID:
21721431
[PubMed - indexed for MEDLINE]
14.

[The role of CSF markers in the early diagnosis of Alzheimer's disease].

Vos SJ, Visser PJ, Verhey FR.

Tijdschr Psychiatr. 2011;53(9):647-53. Dutch.

PMID:
21898322
[PubMed - indexed for MEDLINE]
Free Article
15.

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.

Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B.

Neurology. 2007 Nov 6;69(19):1859-67. Erratum in: Neurology. 2008 May 20;70(21):2016.

PMID:
17984454
[PubMed - indexed for MEDLINE]
16.

Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment.

Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K.

Acta Neurol Scand Suppl. 2003;179:47-51.

PMID:
12603251
[PubMed - indexed for MEDLINE]
17.

Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease.

Dumurgier J, Mouton-Liger F, Lapalus P, Prevot M, Laplanche JL, Hugon J, Paquet C; Groupe d’Investigation du Liquide Cephalorachidien (GIL) Study Network.

PLoS One. 2013;8(1):e53587. doi: 10.1371/journal.pone.0053587. Epub 2013 Jan 8.

PMID:
23320095
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.

Movérare-Skrtic S, Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Zetterberg H, Blennow K, Svensson J.

Exp Gerontol. 2012 Feb;47(2):179-82. doi: 10.1016/j.exger.2011.12.005. Epub 2011 Dec 22.

PMID:
22210159
[PubMed - indexed for MEDLINE]
19.

CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder.

Borroni B, Premi E, Agosti C, Alberici A, Cerini C, Archetti S, Lanari A, Paghera B, Lucchini S, Caimi L, Padovani A.

J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):834-8. doi: 10.1136/jnnp.2010.221853. Epub 2011 Feb 22.

PMID:
21345847
[PubMed - indexed for MEDLINE]
20.

Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts.

Schmand B, Eikelenboom P, van Gool WA; Alzheimer's Disease Neuroimaging Initiative.

J Am Geriatr Soc. 2011 Sep;59(9):1705-10. doi: 10.1111/j.1532-5415.2011.03539.x. Epub 2011 Aug 24.

PMID:
21883100
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk